SS18L2

SS18-like protein 2 · Q9UHA2 · SS18L2 on Sugi Atlas →

0 patent compounds predicted against SS18L2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SS18L2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma PHASE2/PHASE3COMPLETED
A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer PHASE3COMPLETED
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
Dose Escalation Study of Immunomodulatory Nanoparticles PHASE1ACTIVE_NOT_RECRUITING
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma PHASE1WITHDRAWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD) nanCOMPLETED
Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581 nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Epidemiological and Genetic Studies of Body Mass Index nanCOMPLETED
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis nanRECRUITING
Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo) nanWITHDRAWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Serum NGAL IN Patients With Multiple Myeloma nanUNKNOWN
Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin nanCOMPLETED
The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma nanWITHDRAWN
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Genes of Hypertension in African Americans nanCOMPLETED
Chromosome 18 Clinical Research Center nanRECRUITING
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy nanRECRUITING
Polycystic Ovary Syndrome in Type 1 Diabetes nanNOT_YET_RECRUITING
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Developing Genetic Education for Smoking Cessation nanCOMPLETED
PET-MRI F-DOPA Activity in the Mesocorticolimbic System and Depressive Symptoms in the Prediction of Treatment Compatibility nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SS18L2 binder may also engage these)

ProteinNameSimilarity
Q9D174 1.000 Q9D174 →
Q9W5P1 0.991 Q9W5P1 →
Q570U6 0.990 Q570U6 →
Q5XG48 0.988 Q5XG48 →
Q4VC31 0.988 Q4VC31 →
Q16RX1 0.987 Q16RX1 →
Q2TBU8 0.987 Q2TBU8 →
O04211 0.987 O04211 →
Q5ZLS8 0.987 Q5ZLS8 →
B5FX56 0.987 B5FX56 →
Q290F0 0.986 Q290F0 →
Q7Z3E5 0.986 Q7Z3E5 →
Q6C5P0 0.986 Q6C5P0 →
Q9GYU7 0.986 Q9GYU7 →
Q96N23 0.985 Q96N23 →
Q6PBK1 0.985 Q6PBK1 →
Q6PD74 0.985 Q6PD74 →
A0JMA8 0.985 A0JMA8 →
D4A770 0.985 D4A770 →
Q8AWD1 0.985 Q8AWD1 →
Q2KI89 0.985 Q2KI89 →
Q6GN21 0.985 Q6GN21 →
B3DL65 0.985 B3DL65 →
Q4R6N3 0.985 Q4R6N3 →
Q4V7R8 0.985 Q4V7R8 →
Q13503 0.984 Q13503 →
Q8R4Z9 0.984 Q8R4Z9 →
Q9FIT8 0.984 Q9FIT8 →
Q6TNU3 0.984 Q6TNU3 →
A7YY97 0.984 A7YY97 →